FIRST PLACE FINALIST
SECOND PLACE FINALIST
THIRD PLACE FINALIST
FOURTH PLACE FINALIST
FIFTH PLACE FINALIST
SIXTH PLACE FINALIST
ELEVATOR PITCH FIRST PLACE
ELEVATOR PITCH SECOND PLACE
ELEVATOR PITCH THIRD PLACE
AGGIE ANGEL NETWORK INVESTMENT PRIZE
AMERRA VISUALIZATION SERVICES PRIZE
BIOTEX INVESTMENT PRIZE
GOOSE SOCIETY OF TEXAS INVESTMENT PRIZE
PARAGON INNOVATION PRIZE
RAMEY & SCHWALLER IP LEGAL SERVICES PRIZE
RESEARCH VALLEY LAUNCH PRIZE
THOMAS | HORSTEMEYER IP LEGAL SERVICES PRIZE
TEES CLEANTECH PRIZE
TMCX INVESTMENT PRIZE + ACCELERATOR ADMISSION
TMCX ACCELERATOR ADMISSION
SABER is developing an antimicrobial bandage to provide a cost-saving solution by helping hospital staff reduce healthcare associated infections (HAIs). At SABER we are utilizing blue light technology to protect patients, prevent life-threatening infections, provide cost savings to hospitals and the healthcare system, while allowing the comfort of knowing that your wound is safe.
Stream Biomedical is an early stage company founded to address unmet therapeutic needs for individuals suffering as a result of neurological trauma and/or degeneration. Stream is initially developing an acute stroke therapy, a biologic drug which has shown preclinically to be neuroprotective and neuroreparative resulting in dramatic functional improvement.
Sunrise Health is an app for text-based group therapy and peer support where patients with substance abuse or mental health conditions can receive 24/7, stigma-free support. We use artificial intelligence to catch clinically relevant information within messages, so existing providers can focus their time on patients most in need.
Verdegen’s GO! Mosquito Repellent Gel is modeled on the success of hand sanitizer and hand soap wall-mount dispensers. Verdegen’s dispenser-based products are designed to put repellents where people need them, and lets communities/businesses protect their residents/customers.
RevatisAM proposes a global concept in regenerative veterinary medicine based on the combination of growth factors, scaffolds, and regenerative stem cells. RevatisAM hosts the first biobank of autologous pluripotent muscle-derived mesenchymal stem cells, which express a unique healing potential in a variety of pathologies like locomotion disorders.